CSTONE ANNOUNCED NEW DRUG APPROVAL OF CEJEMLY® (SUGEMALIMAB) IN CHINA TO POTENTIALLY RESHAPE THE LANDSCAPE OF IMMUNO-ONCOLOGY THERAPY IN LUNG CANCER
Published by The Street By PR Newswire SUZHOU, China, Dec. 21, 2021 /PRNewswire/ — CStone Pharmaceuticals (the ” Company” or ” CStone”) is pleased to